

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 9.17154876 |
| 2 | positive T cell selection (GO:0043368) | 8.06105193 |
| 3 | negative thymic T cell selection (GO:0045060) | 8.01326602 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.74766769 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.74163995 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 7.00142604 |
| 7 | * T cell selection (GO:0045058) | 6.82000351 |
| 8 | thymic T cell selection (GO:0045061) | 6.77276148 |
| 9 | negative regulation of cell killing (GO:0031342) | 6.75138420 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.75138420 |
| 11 | positive thymic T cell selection (GO:0045059) | 6.73467341 |
| 12 | tolerance induction (GO:0002507) | 6.47794092 |
| 13 | interferon-gamma production (GO:0032609) | 6.37982225 |
| 14 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.22516416 |
| 15 | activated T cell proliferation (GO:0050798) | 6.05922930 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.03693134 |
| 17 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.99481068 |
| 18 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.97561761 |
| 19 | response to interleukin-15 (GO:0070672) | 5.97165058 |
| 20 | regulation of T cell tolerance induction (GO:0002664) | 5.75843748 |
| 21 | V(D)J recombination (GO:0033151) | 5.72617269 |
| 22 | * T cell receptor signaling pathway (GO:0050852) | 5.62961454 |
| 23 | regulation of regulatory T cell differentiation (GO:0045589) | 5.31020558 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 5.28494385 |
| 25 | alpha-beta T cell differentiation (GO:0046632) | 5.07665667 |
| 26 | * T cell costimulation (GO:0031295) | 5.04800731 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.04186748 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04186748 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 5.00107736 |
| 30 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.99466836 |
| 31 | * lymphocyte costimulation (GO:0031294) | 4.98658071 |
| 32 | alpha-beta T cell activation (GO:0046631) | 4.92179013 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 4.87144020 |
| 34 | response to peptidoglycan (GO:0032494) | 4.68326312 |
| 35 | positive regulation of tolerance induction (GO:0002645) | 4.64300455 |
| 36 | * positive regulation of interleukin-2 production (GO:0032743) | 4.58535665 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.56532425 |
| 38 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.50489211 |
| 39 | leukocyte aggregation (GO:0070486) | 4.44060629 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 4.43593192 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 4.43593192 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.43593192 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.43593192 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.43593192 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 4.43593192 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.35225414 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 4.34486216 |
| 48 | regulation of thymocyte apoptotic process (GO:0070243) | 4.25081043 |
| 49 | T cell migration (GO:0072678) | 4.24403374 |
| 50 | * T cell differentiation (GO:0030217) | 4.24281653 |
| 51 | detection of other organism (GO:0098543) | 4.16495145 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.16338819 |
| 53 | immunoglobulin mediated immune response (GO:0016064) | 4.11931146 |
| 54 | regulation of tolerance induction (GO:0002643) | 4.08784506 |
| 55 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.08722888 |
| 56 | detection of bacterium (GO:0016045) | 4.00103155 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.94541555 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.88003122 |
| 59 | regulation of isotype switching (GO:0045191) | 3.85055575 |
| 60 | mast cell activation (GO:0045576) | 3.84791771 |
| 61 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.84312541 |
| 62 | cellular extravasation (GO:0045123) | 3.82308144 |
| 63 | positive regulation of isotype switching (GO:0045830) | 3.78021387 |
| 64 | * regulation of interleukin-2 production (GO:0032663) | 3.76458055 |
| 65 | T cell homeostasis (GO:0043029) | 3.75787146 |
| 66 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.75678626 |
| 67 | Peyers patch development (GO:0048541) | 3.68899854 |
| 68 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.68899854 |
| 69 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.63460875 |
| 70 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.55791833 |
| 71 | T-helper cell differentiation (GO:0042093) | 3.55791833 |
| 72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.53169740 |
| 73 | granulocyte activation (GO:0036230) | 3.51950257 |
| 74 | detection of external biotic stimulus (GO:0098581) | 3.50669733 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.50101779 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49305125 |
| 77 | * T cell activation (GO:0042110) | 3.48496966 |
| 78 | neutrophil activation (GO:0042119) | 3.44409105 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.41057558 |
| 80 | negative regulation of T cell apoptotic process (GO:0070233) | 3.40136149 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.40092242 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39595036 |
| 83 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.39043680 |
| 84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.37011856 |
| 85 | mast cell activation involved in immune response (GO:0002279) | 3.34175030 |
| 86 | mast cell degranulation (GO:0043303) | 3.34175030 |
| 87 | T cell proliferation (GO:0042098) | 3.32528742 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.32518117 |
| 89 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.31479300 |
| 90 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.31479300 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 3.31324438 |
| 92 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.30367948 |
| 93 | lymphocyte homeostasis (GO:0002260) | 3.29508472 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28837356 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28518806 |
| 96 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.27371659 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 3.26829224 |
| 98 | regulation of immunoglobulin production (GO:0002637) | 3.26704867 |
| 99 | positive regulation of mast cell activation (GO:0033005) | 3.26109275 |
| 100 | germinal center formation (GO:0002467) | 3.25424211 |
| 101 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.24302811 |
| 102 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.24302811 |
| 103 | regulation of chronic inflammatory response (GO:0002676) | 3.23412649 |
| 104 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.22968080 |
| 105 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.22968080 |
| 106 | T cell differentiation involved in immune response (GO:0002292) | 3.22968080 |
| 107 | type I interferon signaling pathway (GO:0060337) | 3.21495668 |
| 108 | cellular response to type I interferon (GO:0071357) | 3.21495668 |
| 109 | positive regulation of T cell differentiation (GO:0045582) | 3.21295575 |
| 110 | regulation of antigen processing and presentation (GO:0002577) | 3.21057453 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 3.20439512 |
| 112 | response to type I interferon (GO:0034340) | 3.18303228 |
| 113 | positive regulation of DNA recombination (GO:0045911) | 3.17769798 |
| 114 | * positive regulation of T cell activation (GO:0050870) | 3.16840791 |
| 115 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16616664 |
| 116 | myeloid dendritic cell activation (GO:0001773) | 3.15990290 |
| 117 | macrophage activation (GO:0042116) | 3.14213320 |
| 118 | respiratory burst (GO:0045730) | 3.14140903 |
| 119 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13754971 |
| 120 | regulation of T cell differentiation (GO:0045580) | 3.13078516 |
| 121 | detection of biotic stimulus (GO:0009595) | 3.13016374 |
| 122 | positive regulation of humoral immune response (GO:0002922) | 3.12886161 |
| 123 | T cell lineage commitment (GO:0002360) | 3.12780396 |
| 124 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11857782 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11104651 |
| 126 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.11013885 |
| 127 | regulation of response to interferon-gamma (GO:0060330) | 3.09478213 |
| 128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.09219324 |
| 129 | B cell mediated immunity (GO:0019724) | 3.09013449 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08839315 |
| 131 | microglial cell activation (GO:0001774) | 3.07609752 |
| 132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.04231054 |
| 133 | regulation of leukocyte degranulation (GO:0043300) | 3.04151340 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.02210771 |
| 135 | positive regulation of mast cell degranulation (GO:0043306) | 3.01432916 |
| 136 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01432916 |
| 137 | defense response to protozoan (GO:0042832) | 3.00501542 |
| 138 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.00425645 |
| 139 | positive regulation of interleukin-4 production (GO:0032753) | 3.00420897 |
| 140 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.99968958 |
| 141 | positive regulation of immunoglobulin production (GO:0002639) | 2.99814882 |
| 142 | regulation of alpha-beta T cell activation (GO:0046634) | 2.99675535 |
| 143 | positive regulation of B cell differentiation (GO:0045579) | 2.99515697 |
| 144 | * lymphocyte differentiation (GO:0030098) | 2.99358707 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96083064 |
| 146 | regulation of mast cell activation (GO:0033003) | 2.95919830 |
| 147 | cellular response to interleukin-4 (GO:0071353) | 2.95326518 |
| 148 | T-helper 1 type immune response (GO:0042088) | 2.95291721 |
| 149 | regulation of B cell differentiation (GO:0045577) | 2.95170135 |
| 150 | natural killer cell activation (GO:0030101) | 2.94909030 |
| 151 | somatic cell DNA recombination (GO:0016444) | 2.93992675 |
| 152 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.93992675 |
| 153 | response to protozoan (GO:0001562) | 2.91130229 |
| 154 | response to host immune response (GO:0052572) | 2.89056112 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89056112 |
| 156 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85611531 |
| 157 | amino sugar catabolic process (GO:0046348) | 2.85300568 |
| 158 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81982498 |
| 159 | negative regulation of interleukin-6 production (GO:0032715) | 2.79802912 |
| 160 | regulation of interferon-alpha production (GO:0032647) | 2.78200962 |
| 161 | glycosphingolipid catabolic process (GO:0046479) | 2.76179394 |
| 162 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.75587689 |
| 163 | myeloid leukocyte activation (GO:0002274) | 2.75087969 |
| 164 | negative regulation of innate immune response (GO:0045824) | 2.72156676 |
| 165 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72116818 |
| 166 | mannose metabolic process (GO:0006013) | 2.69496815 |
| 167 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.68080433 |
| 168 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.66893566 |
| 169 | positive regulation of type 2 immune response (GO:0002830) | 2.66465942 |
| 170 | leukocyte degranulation (GO:0043299) | 2.64346398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.03652048 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.82805414 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.13399654 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.12064624 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.93853925 |
| 6 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.84149243 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.77018714 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.56678353 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.51612848 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19722841 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.11005942 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 3.08014533 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.06508039 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04523704 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99091567 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.91894300 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86482896 |
| 18 | * MYB_26560356_Chip-Seq_TH1_Human | 2.77485284 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71413352 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.50905231 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48602555 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.48174120 |
| 23 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.31717974 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28012633 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.14324486 |
| 26 | * MAF_26560356_Chip-Seq_TH2_Human | 2.13830964 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11442938 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08032212 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04182457 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92754301 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90804473 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86235374 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85209180 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83152828 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75425943 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74785177 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71768150 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67992420 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61448489 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58880812 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54470522 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53882278 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49646052 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49618369 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49526064 |
| 46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47366943 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47293797 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43251630 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42053422 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.41562921 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39802101 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34720860 |
| 53 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33293742 |
| 54 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.31940237 |
| 55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30687046 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28947652 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26235414 |
| 58 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23659138 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21736993 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20830195 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19602823 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16029060 |
| 63 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14409037 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12539806 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12119863 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11342806 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10904266 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10598146 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09908510 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07000233 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04662925 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01117536 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01055564 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99445640 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98877369 |
| 76 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98452099 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98309375 |
| 78 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.97698176 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96255735 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95854682 |
| 81 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.92328113 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90589544 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90393298 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89009624 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88616103 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88141715 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87434430 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84980669 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.84307172 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83679489 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83265951 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81831437 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81487099 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81315772 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79683138 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79011589 |
| 97 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.78487882 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76342455 |
| 99 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.75931997 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75779045 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.75570907 |
| 102 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74880900 |
| 103 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74829145 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73556482 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72391078 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71275306 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.70074284 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69159737 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68858453 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68684133 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.68192013 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68025801 |
| 113 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.67330566 |
| 114 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.66748028 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66713471 |
| 116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66322714 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.66145234 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65139851 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.63774354 |
| 120 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63743938 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63596389 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.63185731 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.62468738 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62314958 |
| 125 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.61625706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.24169836 |
| 2 | MP0005671_abnormal_response_to | 4.53674410 |
| 3 | MP0000685_abnormal_immune_system | 3.60609518 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.52415888 |
| 5 | * MP0000703_abnormal_thymus_morphology | 3.20041548 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.12244485 |
| 7 | MP0005387_immune_system_phenotype | 3.04393033 |
| 8 | MP0001790_abnormal_immune_system | 3.04393033 |
| 9 | MP0001800_abnormal_humoral_immune | 3.00811631 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.92115398 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.91709499 |
| 12 | MP0002006_tumorigenesis | 2.83050619 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.80344707 |
| 14 | MP0002398_abnormal_bone_marrow | 2.79358029 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.77274500 |
| 16 | MP0004947_skin_inflammation | 2.56147460 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.54931305 |
| 18 | MP0002405_respiratory_system_inflammati | 2.51722456 |
| 19 | * MP0002723_abnormal_immune_serum | 2.51670135 |
| 20 | MP0001819_abnormal_immune_cell | 2.51144494 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.39511396 |
| 22 | MP0002722_abnormal_immune_system | 2.39192009 |
| 23 | MP0000716_abnormal_immune_system | 2.38086024 |
| 24 | MP0009785_altered_susceptibility_to | 2.32090862 |
| 25 | * MP0010155_abnormal_intestine_physiology | 2.31229429 |
| 26 | MP0002933_joint_inflammation | 2.29720857 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.25060050 |
| 28 | MP0003866_abnormal_defecation | 2.24430760 |
| 29 | MP0001873_stomach_inflammation | 2.15397524 |
| 30 | * MP0000689_abnormal_spleen_morphology | 2.15092433 |
| 31 | MP0003436_decreased_susceptibility_to | 2.14564722 |
| 32 | MP0003303_peritoneal_inflammation | 2.14134653 |
| 33 | MP0002396_abnormal_hematopoietic_system | 2.13145076 |
| 34 | MP0005025_abnormal_response_to | 2.00372615 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.89733108 |
| 36 | MP0002429_abnormal_blood_cell | 1.89660618 |
| 37 | MP0009840_abnormal_foam_cell | 1.89641647 |
| 38 | MP0002132_abnormal_respiratory_system | 1.88262812 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.82159365 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.76038930 |
| 41 | MP0003075_altered_response_to | 1.71649403 |
| 42 | MP0000604_amyloidosis | 1.64144184 |
| 43 | MP0005451_abnormal_body_composition | 1.61572642 |
| 44 | MP0004510_myositis | 1.61315594 |
| 45 | MP0003724_increased_susceptibility_to | 1.60957793 |
| 46 | MP0000343_altered_response_to | 1.57434478 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.57352552 |
| 48 | MP0001853_heart_inflammation | 1.51791182 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.51295273 |
| 50 | MP0002822_catalepsy | 1.49904289 |
| 51 | MP0005310_abnormal_salivary_gland | 1.47964747 |
| 52 | MP0003828_pulmonary_edema | 1.46671990 |
| 53 | MP0003690_abnormal_glial_cell | 1.45077338 |
| 54 | MP0002419_abnormal_innate_immunity | 1.38648880 |
| 55 | MP0008260_abnormal_autophagy | 1.35078048 |
| 56 | MP0008004_abnormal_stomach_pH | 1.31579158 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.30457098 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.30267351 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.30267351 |
| 60 | MP0005409_darkened_coat_color | 1.29725168 |
| 61 | MP0009278_abnormal_bone_marrow | 1.28547472 |
| 62 | MP0005166_decreased_susceptibility_to | 1.27584950 |
| 63 | MP0000490_abnormal_crypts_of | 1.22090337 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 1.21280905 |
| 65 | MP0004381_abnormal_hair_follicle | 1.19076331 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.18043696 |
| 67 | MP0001849_ear_inflammation | 1.16772691 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.15992171 |
| 69 | MP0002009_preneoplasia | 1.15943599 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.11240781 |
| 71 | MP0000858_altered_metastatic_potential | 1.07542249 |
| 72 | MP0004883_abnormal_blood_vessel | 1.06271773 |
| 73 | MP0008057_abnormal_DNA_replication | 1.05543156 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 1.00909281 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.97692592 |
| 76 | MP0010094_abnormal_chromosome_stability | 0.97052358 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 0.96994884 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.96504653 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.96452357 |
| 80 | MP0001851_eye_inflammation | 0.96414188 |
| 81 | MP0005164_abnormal_response_to | 0.94595921 |
| 82 | MP0005390_skeleton_phenotype | 0.92516770 |
| 83 | MP0003787_abnormal_imprinting | 0.91936019 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.91893847 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.90359791 |
| 86 | MP0002254_reproductive_system_inflammat | 0.87291631 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.84953206 |
| 88 | MP0003448_altered_tumor_morphology | 0.84848954 |
| 89 | * MP0006082_CNS_inflammation | 0.83773634 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.83665291 |
| 91 | MP0008469_abnormal_protein_level | 0.83230641 |
| 92 | MP0005023_abnormal_wound_healing | 0.72688909 |
| 93 | MP0001243_abnormal_dermal_layer | 0.71435652 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.71324570 |
| 95 | MP0003329_amyloid_beta_deposits | 0.71059248 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.70783656 |
| 97 | MP0001542_abnormal_bone_strength | 0.67782479 |
| 98 | MP0008569_lethality_at_weaning | 0.67463296 |
| 99 | MP0003077_abnormal_cell_cycle | 0.66855323 |
| 100 | * MP0000920_abnormal_myelination | 0.66348684 |
| 101 | MP0006054_spinal_hemorrhage | 0.62911625 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.62855836 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.62475960 |
| 104 | MP0008874_decreased_physiological_sensi | 0.62143047 |
| 105 | MP0000609_abnormal_liver_physiology | 0.61314778 |
| 106 | MP0003279_aneurysm | 0.60604854 |
| 107 | MP0003795_abnormal_bone_structure | 0.59412577 |
| 108 | MP0005165_increased_susceptibility_to | 0.58326076 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.57314009 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.57172433 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.56467208 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.56371018 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.54003624 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.52753757 |
| 115 | MP0001663_abnormal_digestive_system | 0.50494658 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.50491188 |
| 117 | MP0008770_decreased_survivor_rate | 0.49721643 |
| 118 | MP0000249_abnormal_blood_vessel | 0.49488364 |
| 119 | MP0000367_abnormal_coat/_hair | 0.49194666 |
| 120 | MP0009115_abnormal_fat_cell | 0.48510042 |
| 121 | MP0009764_decreased_sensitivity_to | 0.48083800 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.47618164 |
| 123 | MP0001881_abnormal_mammary_gland | 0.47502637 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.46175775 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.45954569 |
| 126 | MP0003045_fibrosis | 0.45008654 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.44990546 |
| 128 | MP0000627_abnormal_mammary_gland | 0.43890235 |
| 129 | MP0002970_abnormal_white_adipose | 0.43309982 |
| 130 | MP0003091_abnormal_cell_migration | 0.41442411 |
| 131 | MP0000313_abnormal_cell_death | 0.40510056 |
| 132 | MP0003959_abnormal_lean_body | 0.40270121 |
| 133 | MP0009763_increased_sensitivity_to | 0.39680870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.60911223 |
| 2 | Abnormality of T cell number (HP:0011839) | 9.16089086 |
| 3 | Abnormality of B cell number (HP:0010975) | 7.63290163 |
| 4 | B lymphocytopenia (HP:0010976) | 7.63290163 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 7.45330914 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 6.92593280 |
| 7 | Combined immunodeficiency (HP:0005387) | 6.87290356 |
| 8 | Abnormality of T cells (HP:0002843) | 5.92965153 |
| 9 | Thyroiditis (HP:0100646) | 5.88830908 |
| 10 | Hypoplasia of the thymus (HP:0000778) | 5.83465355 |
| 11 | Eosinophilia (HP:0001880) | 5.76899216 |
| 12 | Recurrent viral infections (HP:0004429) | 5.75645415 |
| 13 | Recurrent abscess formation (HP:0002722) | 5.27480880 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.25951534 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.25951534 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 5.25951534 |
| 17 | Abnormality of macrophages (HP:0004311) | 5.24851261 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 5.18122870 |
| 19 | Abnormality of eosinophils (HP:0001879) | 4.97445392 |
| 20 | Recurrent fungal infections (HP:0002841) | 4.95930588 |
| 21 | Granulocytopenia (HP:0001913) | 4.80214381 |
| 22 | IgG deficiency (HP:0004315) | 4.65386952 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 4.46650542 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.40120902 |
| 25 | Stomatitis (HP:0010280) | 4.30898092 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 4.24410136 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 4.18290506 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.14640176 |
| 29 | Leukocytosis (HP:0001974) | 4.00384665 |
| 30 | Abnormality of the fingertips (HP:0001211) | 3.95670248 |
| 31 | Dysostosis multiplex (HP:0000943) | 3.79909095 |
| 32 | IgM deficiency (HP:0002850) | 3.70225541 |
| 33 | Myositis (HP:0100614) | 3.62170930 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.62055682 |
| 35 | Loss of speech (HP:0002371) | 3.59127971 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.48913063 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35778913 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35778913 |
| 39 | Disinhibition (HP:0000734) | 3.34554003 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29997567 |
| 41 | Hypoproteinemia (HP:0003075) | 3.26887077 |
| 42 | Nasal polyposis (HP:0100582) | 3.11901583 |
| 43 | Chronic diarrhea (HP:0002028) | 3.10666061 |
| 44 | Pustule (HP:0200039) | 3.07621214 |
| 45 | Gingivitis (HP:0000230) | 3.00461659 |
| 46 | Optic neuritis (HP:0100653) | 2.99295187 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.99295187 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.97878160 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.93327967 |
| 50 | Mutism (HP:0002300) | 2.90960451 |
| 51 | Purpura (HP:0000979) | 2.88004981 |
| 52 | Chronic otitis media (HP:0000389) | 2.87962725 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.87930857 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.87930857 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.87930857 |
| 56 | Increased IgM level (HP:0003496) | 2.84270949 |
| 57 | Orchitis (HP:0100796) | 2.81432029 |
| 58 | Amyloidosis (HP:0011034) | 2.80019574 |
| 59 | Glomerulonephritis (HP:0000099) | 2.76606529 |
| 60 | Joint swelling (HP:0001386) | 2.76300675 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.75775965 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75775965 |
| 63 | Meningitis (HP:0001287) | 2.73692143 |
| 64 | IgA deficiency (HP:0002720) | 2.73051539 |
| 65 | Hematochezia (HP:0002573) | 2.59766978 |
| 66 | Urticaria (HP:0001025) | 2.58343031 |
| 67 | Hemoptysis (HP:0002105) | 2.57641707 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.56449841 |
| 69 | Increased serum ferritin (HP:0003281) | 2.56441127 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.54840764 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.54807355 |
| 72 | Lymphoma (HP:0002665) | 2.54292593 |
| 73 | Lymphopenia (HP:0001888) | 2.53767774 |
| 74 | Eczematoid dermatitis (HP:0000976) | 2.53112885 |
| 75 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.46630933 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46031736 |
| 77 | Petechiae (HP:0000967) | 2.42816904 |
| 78 | Vasculitis (HP:0002633) | 2.42594611 |
| 79 | Basal cell carcinoma (HP:0002671) | 2.39037139 |
| 80 | Increased density of long bones (HP:0006392) | 2.33938152 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30256043 |
| 82 | Complement deficiency (HP:0004431) | 2.27678915 |
| 83 | Persistence of primary teeth (HP:0006335) | 2.26165887 |
| 84 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.24164007 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.24032159 |
| 86 | Encephalitis (HP:0002383) | 2.21483382 |
| 87 | Colitis (HP:0002583) | 2.18894856 |
| 88 | Cellulitis (HP:0100658) | 2.18548750 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 2.18427177 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.17849907 |
| 91 | Polyneuropathy (HP:0001271) | 2.17603906 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 2.17263662 |
| 93 | Axonal loss (HP:0003447) | 2.16376114 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.13295954 |
| 95 | Cheilitis (HP:0100825) | 2.11018954 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.09716956 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 2.09623131 |
| 98 | Erythroderma (HP:0001019) | 2.09420932 |
| 99 | Abnormality of complement system (HP:0005339) | 2.08176096 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.06585487 |
| 101 | Episodic fever (HP:0001954) | 2.05982188 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 2.04376321 |
| 103 | Recurrent sinusitis (HP:0011108) | 2.03316630 |
| 104 | Increased IgE level (HP:0003212) | 2.02865502 |
| 105 | Neurofibrillary tangles (HP:0002185) | 2.01882415 |
| 106 | Papilloma (HP:0012740) | 2.01843502 |
| 107 | Verrucae (HP:0200043) | 2.01843502 |
| 108 | Anorexia (HP:0002039) | 2.01709354 |
| 109 | Arterial thrombosis (HP:0004420) | 2.00750195 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 2.00252865 |
| 111 | Malnutrition (HP:0004395) | 2.00215435 |
| 112 | Bronchitis (HP:0012387) | 1.98860232 |
| 113 | Abnormality of the thymus (HP:0000777) | 1.98019261 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.96873079 |
| 115 | Chest pain (HP:0100749) | 1.96735008 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.95997069 |
| 117 | Restrictive lung disease (HP:0002091) | 1.95885923 |
| 118 | Basal ganglia calcification (HP:0002135) | 1.93020616 |
| 119 | Myocardial infarction (HP:0001658) | 1.91931392 |
| 120 | Nuclear cataract (HP:0100018) | 1.91538997 |
| 121 | Ureteral stenosis (HP:0000071) | 1.89809824 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.88568580 |
| 123 | Volvulus (HP:0002580) | 1.87008231 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 1.84528421 |
| 125 | Bicuspid aortic valve (HP:0001647) | 1.84130901 |
| 126 | Pulmonary embolism (HP:0002204) | 1.84110284 |
| 127 | Bronchiectasis (HP:0002110) | 1.79544156 |
| 128 | Ureteral obstruction (HP:0006000) | 1.75217717 |
| 129 | Dislocated radial head (HP:0003083) | 1.74198795 |
| 130 | Mediastinal lymphadenopathy (HP:0100721) | 1.73463987 |
| 131 | Abnormality of the prostate (HP:0008775) | 1.69650384 |
| 132 | Cellular immunodeficiency (HP:0005374) | 1.68600675 |
| 133 | Recurrent skin infections (HP:0001581) | 1.68353587 |
| 134 | Recurrent otitis media (HP:0000403) | 1.62942201 |
| 135 | Epistaxis (HP:0000421) | 1.62672121 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.62208702 |
| 137 | Abnormality of the radial head (HP:0003995) | 1.61065746 |
| 138 | Obstructive lung disease (HP:0006536) | 1.56890611 |
| 139 | Chronic obstructive pulmonary disease (HP:0006510) | 1.56890611 |
| 140 | Gingival bleeding (HP:0000225) | 1.54632346 |
| 141 | Gangrene (HP:0100758) | 1.49872791 |
| 142 | Abnormality of the pleura (HP:0002103) | 1.49736575 |
| 143 | Prolonged bleeding time (HP:0003010) | 1.48475927 |
| 144 | Deep philtrum (HP:0002002) | 1.48348695 |
| 145 | Periodontitis (HP:0000704) | 1.46806414 |
| 146 | Emphysema (HP:0002097) | 1.45097031 |
| 147 | Hepatitis (HP:0012115) | 1.44871841 |
| 148 | Abnormality of oral frenula (HP:0000190) | 1.44355242 |
| 149 | Thrombocytosis (HP:0001894) | 1.44145417 |
| 150 | Cutis marmorata (HP:0000965) | 1.43948577 |
| 151 | Broad palm (HP:0001169) | 1.42321266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.33336764 |
| 2 | MAP4K1 | 5.46468600 |
| 3 | RIPK4 | 3.88832060 |
| 4 | ITK | 3.38038393 |
| 5 | ZAP70 | 3.12366473 |
| 6 | JAK3 | 2.95441635 |
| 7 | FGFR4 | 2.95114298 |
| 8 | STK10 | 2.56628731 |
| 9 | GRK6 | 2.54835764 |
| 10 | CDK12 | 2.52094392 |
| 11 | ERN1 | 2.34087949 |
| 12 | TYK2 | 2.28453617 |
| 13 | FGFR3 | 2.26197586 |
| 14 | IKBKE | 2.02439713 |
| 15 | MAP3K3 | 1.92626266 |
| 16 | LCK | 1.91436773 |
| 17 | NLK | 1.79920379 |
| 18 | FGR | 1.78276146 |
| 19 | IRAK3 | 1.77935930 |
| 20 | MAP3K14 | 1.76330023 |
| 21 | JAK1 | 1.74980774 |
| 22 | MAP3K11 | 1.64188066 |
| 23 | HCK | 1.64185139 |
| 24 | SYK | 1.63772881 |
| 25 | GRK7 | 1.62372872 |
| 26 | TAOK2 | 1.53107706 |
| 27 | CSK | 1.51653734 |
| 28 | MAP3K7 | 1.51042763 |
| 29 | TEC | 1.47789882 |
| 30 | PDGFRB | 1.43925553 |
| 31 | EEF2K | 1.40751087 |
| 32 | TYRO3 | 1.40229173 |
| 33 | SIK2 | 1.39763434 |
| 34 | MAPK7 | 1.36018598 |
| 35 | MATK | 1.29995122 |
| 36 | MAP3K10 | 1.26706583 |
| 37 | PRKCH | 1.22448691 |
| 38 | MAP3K13 | 1.21801019 |
| 39 | MAP3K1 | 1.17584896 |
| 40 | RIPK1 | 1.17458307 |
| 41 | CDC42BPA | 1.09525785 |
| 42 | JAK2 | 1.09134378 |
| 43 | PKN2 | 1.08595673 |
| 44 | MARK2 | 1.06384202 |
| 45 | MST4 | 1.03197098 |
| 46 | BMPR2 | 1.00603249 |
| 47 | BTK | 1.00379439 |
| 48 | MARK3 | 0.97438522 |
| 49 | BRD4 | 0.93918422 |
| 50 | * PRKCQ | 0.92548194 |
| 51 | IKBKB | 0.92423589 |
| 52 | TBK1 | 0.91455042 |
| 53 | CHUK | 0.87061975 |
| 54 | YES1 | 0.84622656 |
| 55 | MOS | 0.81963517 |
| 56 | SIK3 | 0.77981002 |
| 57 | CAMKK1 | 0.77027728 |
| 58 | IRAK1 | 0.77008576 |
| 59 | HIPK2 | 0.76522793 |
| 60 | EPHB1 | 0.75216409 |
| 61 | FGFR2 | 0.73563271 |
| 62 | EPHA3 | 0.73344800 |
| 63 | LRRK2 | 0.73249195 |
| 64 | CLK1 | 0.71595478 |
| 65 | TNK2 | 0.71418726 |
| 66 | TRIB3 | 0.70331410 |
| 67 | PDPK1 | 0.70171600 |
| 68 | PIM1 | 0.70091087 |
| 69 | ALK | 0.68571161 |
| 70 | DDR2 | 0.67593198 |
| 71 | TGFBR2 | 0.66289103 |
| 72 | CDK6 | 0.64707648 |
| 73 | IRAK2 | 0.64549054 |
| 74 | NTRK2 | 0.64306460 |
| 75 | RPS6KA4 | 0.63687270 |
| 76 | MAPK12 | 0.61567491 |
| 77 | FES | 0.61460270 |
| 78 | CSF1R | 0.61193936 |
| 79 | CDK4 | 0.61191377 |
| 80 | KSR2 | 0.60115914 |
| 81 | TAOK1 | 0.58142336 |
| 82 | MELK | 0.55634844 |
| 83 | ACVR1B | 0.53550247 |
| 84 | NME2 | 0.53391237 |
| 85 | CAMK4 | 0.51449615 |
| 86 | MAPK4 | 0.51177392 |
| 87 | RPS6KC1 | 0.51124151 |
| 88 | RPS6KL1 | 0.51124151 |
| 89 | INSR | 0.50956554 |
| 90 | TAOK3 | 0.50678892 |
| 91 | CAMK1D | 0.50348905 |
| 92 | SGK3 | 0.50330044 |
| 93 | MAP3K5 | 0.49170662 |
| 94 | PDK1 | 0.48849745 |
| 95 | KIT | 0.48374085 |
| 96 | LYN | 0.47979186 |
| 97 | CSNK1A1L | 0.47086550 |
| 98 | FYN | 0.46964905 |
| 99 | MAP2K6 | 0.46182401 |
| 100 | FGFR1 | 0.45911238 |
| 101 | SMG1 | 0.45209168 |
| 102 | PRKD2 | 0.42352226 |
| 103 | STK4 | 0.42035006 |
| 104 | RPS6KA6 | 0.41402412 |
| 105 | TTN | 0.40734868 |
| 106 | CAMKK2 | 0.40495169 |
| 107 | DYRK1B | 0.38424172 |
| 108 | PIM2 | 0.38314728 |
| 109 | IGF1R | 0.37986290 |
| 110 | PRPF4B | 0.36240681 |
| 111 | PTK6 | 0.36133987 |
| 112 | CDK9 | 0.35609891 |
| 113 | BLK | 0.35074668 |
| 114 | PIK3CG | 0.34628956 |
| 115 | TESK2 | 0.33867979 |
| 116 | EGFR | 0.32671832 |
| 117 | ABL1 | 0.31944750 |
| 118 | MAPK3 | 0.31458820 |
| 119 | RET | 0.31439466 |
| 120 | DMPK | 0.31356698 |
| 121 | CHEK1 | 0.31049676 |
| 122 | ICK | 0.30818096 |
| 123 | RPS6KA2 | 0.30632961 |
| 124 | MAPKAPK2 | 0.30164656 |
| 125 | SIK1 | 0.27978599 |
| 126 | IRAK4 | 0.27060912 |
| 127 | NEK2 | 0.26884718 |
| 128 | MAPK11 | 0.25538768 |
| 129 | MAPK8 | 0.25476083 |
| 130 | WNK1 | 0.24723706 |
| 131 | MAP2K3 | 0.23370236 |
| 132 | FLT3 | 0.19474719 |
| 133 | MAPK9 | 0.19099867 |
| 134 | MAP3K8 | 0.18249856 |
| 135 | CAMK1 | 0.17888129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 6.18141209 |
| 2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.42319465 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.34874100 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.34108645 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.88401401 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.69332681 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52156146 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.51634552 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.36369007 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.35530984 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.11410070 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91594193 |
| 13 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75319517 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.74174162 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64821923 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64768939 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62157134 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61285373 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58913491 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55753727 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.49075212 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.43799595 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43366018 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42446235 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41495730 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.40408847 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37846571 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36178123 |
| 29 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36165362 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32296058 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.28824705 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22804836 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22797293 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21820643 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21475273 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20804304 |
| 37 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19526690 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12855588 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09603816 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.08363172 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05986948 |
| 42 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03777370 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03395806 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02754071 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02592018 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01930901 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97308914 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.97145361 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.87688686 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87577225 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87449023 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85491886 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83819576 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82967428 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82760647 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82192061 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81971576 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80795179 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.80604811 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.80357602 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.79719812 |
| 62 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74869567 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74831686 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74214527 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.72467099 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71446575 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70554248 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69591886 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69047453 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.68321426 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.67621083 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67550633 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66991462 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66897986 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65466600 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63138593 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61823538 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61154415 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.61113212 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59532893 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58322565 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56468970 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.56331621 |
| 84 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53225358 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53189475 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51810247 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51491681 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50373279 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49225597 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47027369 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.46711019 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46655496 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.46447540 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46301408 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46056584 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.45907703 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45772607 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43663216 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42567690 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.42259752 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42204478 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.40730470 |
| 103 | Spliceosome_Homo sapiens_hsa03040 | 0.40449259 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38589546 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.37841385 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37527191 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37126951 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.36692381 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36679445 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.35150309 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.34851809 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33285084 |
| 113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32980690 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32052564 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31853841 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31699798 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31185111 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29795970 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28504575 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27974427 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25712331 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24295465 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20820385 |

